Filing Details
- Accession Number:
- 0001209191-13-053881
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-11-25 10:30:47
- Reporting Period:
- 2013-11-22
- Filing Date:
- 2013-11-25
- Accepted Time:
- 2013-11-25 10:30:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
850261 | Sorrento Therapeutics Inc. | SRNE | Services-Commercial Physical & Biological Research (8731) | 330344842 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
944809 | Opko Health, Inc. | 4400 Biscayne Blvd. Miami FL 33137 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2013-11-22 | 8,471 | $8.50 | 2,173,859 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Represents the weighted average purchase price for the transactions as reported on this line. The range of prices for the transactions reported on this line was $8.48 to $8.50. The reporting person will provide to the Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased and sold at each separate price.